Sentence examples for applicable trial from inspiring English sources

Item 1: Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym "A multi-center, investigator-blinded, randomized, 12-month, parallel-group, non-inferiority study to compare the efficacy of 1.6 to 2.4 g Asacol® Therapy QD [once daily] versus divided dose (BID [twice daily]) in the maintenance of remission of ulcerative colitis".

Overall, a median, per drug, of 71% (IQR 0 100%) of applicable trials complied with FDAAA (see table 2).

Overall, per drug, a median of 67% (IQR 0 100%) of applicable trials fully complied with the law (see table 2), with considerable variation.

We reviewed whether FDAAA applicable trials (for both the 'controlled' and 'interventional' samples) had timely registration and reporting as defined by FDAAA.

The PRECIS Review PRR) tool was developed by Koppenaal et al. [ 21] to evaluate systematic reviews and the randomized controlled trials used in the review to help policy makers decide on applicable trials to inform their work.

As a result of the US FDA Amendments Act, Section 801, passed in 2007, ClinicalTrials.gov has required (since September 2008) the posting of results of aggregate data from applicable trials by researchers within 12 months of completion.

The legal requirements enshrined in FDAAA (table 2) offer at least two potential interpretations for what constitutes an applicable clinical trial: controlled and interventional trials.

As most trials were international multicentre studies our findings may well be applicable to trial reports from other settings or countries.

While that characterization may be somewhat applicable to trial judges, it has nothing to do with the work of appellate judges, state or federal.

There are essentially no directly applicable clinical trial data on glucose control for large segments of the older diabetic patient population.

8 Applicable clinical trials include phase II to IV interventional controlled trials registered after the enactment of the FDAAA 801 (or ongoing at this date) involving drugs, biologic agents, or devices (only after FDA approval for any use) regardless of sponsorship and involving at least one US site, whatever the primary country of origin of the trials.